Author

H. H. Wang

Observed names: Haobiao WANG, Haobiao Wang, WANG Haobiao

Institution: Shenzhen Blood Center

Observed institutions: University Medical Center Groningen, University of Groningen, Anhui University of Science and Technology, Shenzhen Blood Center

ORCID: 0000-0002-2077-5765

Observed ORCID: 0000-0002-2077-5765

OpenAlex ID: A5113383551

Potential Predictive Immune and Metabolic Biomarkers of Tumor Microenvironment Regarding Pathological and Clinical Response in Esophageal Cancer After Neoadjuvant Chemoradiotherapy: A Systematic Review

2023 · H. H. Wang, E. N. Steffens, et al. · Annals of Surgical Oncology · 18

Development and validation of a prognostic nomogram for esophageal cancer patients based on SEER Asian population

2024 · Xinwei Guo, Lang Qin, et al. · Scientific Reports · 3

ASO Author Reflections: Pathologic Complete Response of Extended CROSS Criteria Patients with Esophageal Cancer

2020 · H. H. Wang, J. Th. M. Plukker, et al. · Annals of Surgical Oncology · 3

ASO Author Reflections: A Systematic Review on Predictive Immune and Metabolic Biomarkers to Predict Clinical and Pathological Response in Esophageal Cancer

2023 · H. H. Wang, E. N. Steffens, et al. · Annals of Surgical Oncology · 1

HTLV Seroprevalence and Associated Factors Among Blood Donors in Shenzhen, China: A Cross-Sectional Study with Longitudinal Follow-Up, 2013–2022

2026 · Xiaoxuan Xu, Dian Wang, et al. · Viruses

Metastatic mismatch repair deficient oesophageal squamous cell carcinoma leading to diagnosis of Lynch syndrome with a complete response to nivolumab treatment

2025 · H. H. Wang, G. Kats-Ugurlu, et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin

Works count: 9

Citation count: 25

H-index: 3

I10-index: 1